A detailed history of Assenagon Asset Management S.A. transactions in Care Dx, Inc. stock. As of the latest transaction made, Assenagon Asset Management S.A. holds 65,787 shares of CDNA stock, worth $1.54 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
65,787
Previous 166,305 60.44%
Holding current value
$1.54 Million
Previous $2.58 Million 20.49%
% of portfolio
0.0%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

SELL
$14.41 - $33.99 $1.45 Million - $3.42 Million
-100,518 Reduced 60.44%
65,787 $2.05 Million
Q2 2024

Jul 18, 2024

SELL
$7.56 - $16.15 $1.44 Million - $3.07 Million
-190,268 Reduced 53.36%
166,305 $2.58 Million
Q1 2024

Apr 24, 2024

SELL
$7.96 - $12.37 $1.75 Million - $2.72 Million
-219,774 Reduced 38.13%
356,573 $3.78 Million
Q4 2023

Jan 17, 2024

SELL
$4.9 - $12.86 $277,972 - $729,534
-56,729 Reduced 8.96%
576,347 $6.92 Million
Q3 2023

Nov 06, 2023

SELL
$7.0 - $11.26 $3.52 Million - $5.66 Million
-502,321 Reduced 44.24%
633,076 $4.43 Million
Q2 2023

Jul 25, 2023

SELL
$7.61 - $9.46 $220,469 - $274,065
-28,971 Reduced 2.49%
1,135,397 $9.65 Million
Q1 2023

Apr 18, 2023

BUY
$8.83 - $17.61 $8.7 Million - $17.3 Million
985,010 Added 549.19%
1,164,368 $10.6 Million
Q4 2022

Jan 12, 2023

BUY
$10.88 - $20.05 $688,432 - $1.27 Million
63,275 Added 54.51%
179,358 $2.05 Million
Q3 2022

Oct 27, 2022

SELL
$16.06 - $26.39 $14.2 Million - $23.4 Million
-885,405 Reduced 88.41%
116,083 $1.98 Million
Q2 2022

Jul 27, 2022

BUY
$20.49 - $39.72 $17 Million - $33 Million
831,629 Added 489.6%
1,001,488 $21.5 Million
Q1 2022

Apr 25, 2022

BUY
$28.19 - $46.6 $249,932 - $413,155
8,866 Added 5.51%
169,859 $6.28 Million
Q4 2021

Feb 01, 2022

BUY
$41.2 - $73.6 $6.63 Million - $11.8 Million
160,993 New
160,993 $7.32 Million

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.25B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Assenagon Asset Management S.A. Portfolio

Follow Assenagon Asset Management S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Assenagon Asset Management S.A. with notifications on news.